A novel AKT inhibitor, AZD5363, inhibits phosphorylation of AKT downstream molecules, and activates phosphorylation of mTOR and SMG-1 dependent on the liver cancer cell type

Yuncheng Zhang(Shandong Provincial Hospital), Jun Liu(Shandong University)

Oncology Letters

January 14, 2016

10.3892/ol.2016.4111

Cited by 29

Related Papers

Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol

|Cell Research|2018|123

Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma

|World Journal of Gastroenterology|2020|35

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma

|BioMed Research International|2020|20

Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes

|Diabetes Metabolic Syndrome and Obesity|2021|9

<p>Mesencephalic Astrocyte-Derived Neurotrophic Factor, a Prognostic Factor of Cholangiocarcinoma, Affects Sorafenib Sensitivity of Cholangiocarcinoma Cells by Deteriorating ER Stress</p>

|OncoTargets and Therapy|2020|7